Saving changes...

Done

Error

2018 ACCP Journal of Clinical Pharmacology Journal CE February | Effect of Vitamin D in the Prevention of Myocardial Injury Following Elective Percutaneous Coronary Intervention:A Pilot Randomized Clinical Trial

2018 ACCP Journal of Clinical Pharmacology Journal CE February | Effect of Vitamin D in the Prevention of Myocardial Injury Following Elective Percutaneous Coronary Intervention:A Pilot Randomized Clinical Trial

2018 ACCP Journal of Clinical Pharmacology Journal CE February | Effect of Vitamin D in the Prevention of Myocardial Injury Following Elective Percutaneous Coronary Intervention:A Pilot Randomized Clinical Trial

Naser Aslanabadi,MD and others
Naser Aslanabadi,MD and others
on behalf of American College of Clinical Pharmacology

$10.00 $ 10.00 $ 10.00

$ 10.00 $ 10.00 $ 10.00
$ 10.00 $ 10.00 $ 10.00
Normal Price: $10.00 $10.00

Review:

Launch date: 05 Jun 2018
Expiry Date: 01 Feb 2021

Last updated: 16 Apr 2019

Reference: 189575

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

Vitamin D from this study was shown not to produce any significant benefits in patients with PCI. However, use of vitamin D lead to no adverse effects.

Objectives

Objective 1:
Describe the possible mechanism of action for the role of vitamin D in the pathogenesis of cardiovascular disease.
Objective 2:
Identify the doses used for vitamin D and its possible use in percutaneous coronary intervention (PCI).
Objective 3:
Compare and contrast the study efficacy and safety results between the vitamin D treatment the control group.
Objective 4:
Discuss the study’s limitations for vitamin D’s role in the treatment of PCI.
Naser Aslanabadi,MD and others

Author Information Play Video Bio

Naser Aslanabadi,MD and others
on behalf of American College of Clinical Pharmacology

In the 1960s, a group of eminent physicians formulated the concept of an organization dedicated to a new branch of pharmacology that dealt with the effectiveness and safety of drugs in man. As a result of their efforts, the American College of Clinical Pharmacology (ACCP) was founded on September 11, 1969. Today, ACCP consists of a full spectrum of clinical pharmacology professionals from academia, industry, government and clinical settings who span the scope from research and drug development to patient-related care and who remain dedicated to advancing clinical pharmacology with the ultimate goal of enhancing patient care.

As an organization whose primary role is education, ACCP does not concentrate on any one aspect of the discipline. Rather, it seeks to address the educational needs of its diverse membership and all healthcare professionals, covering a range of topics that span the entire area of the interaction between drugs and humans. These areas include, but are not limited to, pharmaceutical chemistry, biochemistry, drug metabolism, pharmacokinetics, pharmacodynamics, pharmacometrics, pharmacogenomics clinical pharmacology practice in the outpatient and inpatient settings, human toxicology, drug interactions and clinical drug trials. The diversity of ACCP is expressed not only in the composition of its membership, but also in its leadership. Maintaining a balance of elected Regents and Officers from all pertinent professional backgrounds ensures that ACCP remains attuned to the needs of all professionals engaged in the practice of or with a strong interest in clinical pharmacology, from the research laboratory (academic and industrial) to the classroom, and from clinical trials to improved patient care.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 1.00 Credits

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error